Svas Biosana SpA (SVSB)

Milan

Currency in EUR

SVSB Pro Research

8.20

-0.18(-2.15%)

Closed·11:35:59

Fair Value

Unlock Value

Day's Range

8.20

8.24

52 wk Range

7.68

10.80

SVSB Income Statement

Assess the Svas Biosana income statement, providing a detailed view of the company’s financial performance across activities. This statement outlines key financial figures such as revenue, expenses, operating income, and net income. Assess the SVSB net worth.

Period Ending:

2018

31/12

2019

31/12

2020

31/12

2021

31/12

2022

31/12

2023

31/12

2024

31/12

2025

31/12

Total Revenues

aa.aa

121.63

122.29

141.56

Total Revenues Growth

aa.aa

+22.22%

+0.54%

+15.76%

Cost Of Revenues

aa.aa

89.37

87.92

101.47

Gross Profit

aa.aa

32.26

34.37

40.08

Gross Profit Growth

aa.aa

+12.26%

+6.54%

+16.64%

Gross Profit Margin %

aa.aa

26.52%

28.1%

28.32%

Other Operating Expenses, Total

aa.aa

23.69

24.56

27.85

	Other Operating Expenses, Total Growth
	R&D Expenses
	Selling General & Admin Expenses
	Other Operating Expenses

aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	+5.52%	+3.69%	+13.37%
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	-	-	-
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	16.3	16.68	18.88
aa.aa	aa.aa	aa.aa	aa.aa	aa.aa	2.37	2.63	3.17

Operating Income

aa.aa

8.57

9.8

12.24

Operating Income Growth

aa.aa

+36.35%

+14.43%

+24.83%

EBIT Margin %

aa.aa

7.04%

8.02%

8.64%

Net Interest Expenses

aa.aa

-3.68

-4.25

-4.04

Net Interest Expenses Growth

aa.aa

-104.19%

-15.35%

+4.84%

Interest Expense, Total

aa.aa

-3.79

-4.36

-4.13

Interest And Investment Income

aa.aa

0.11

0.08

Other Non Operating Expenses, Total

aa.aa

0.63

0.6

0.5

EBT, Excl. Unusual Items

aa.aa

5.51

6.16

8.69

Gain (Loss) On Sale Of Assets

aa.aa

Other Unusual Items, Total

aa.aa

EBT, Incl. Unusual Items

aa.aa

6.8

8.01

9.14

EBT, Incl. Unusual Items Growth

aa.aa

+45.98%

+17.82%

+14.07%

EBT, Incl. Unusual Items Margin

aa.aa

5.59%

6.55%

6.45%

Income Tax Expense

aa.aa

1.67

2.13

2.37

Net Income to Company

aa.aa

5.13

5.88

6.77

Minority Interest

aa.aa

-0

Net Income

aa.aa

5.12

5.87

6.77

Net Income Growth

aa.aa

+43.52%

+14.68%

+15.24%

Net Income Margin %

aa.aa

4.21%

4.8%

4.78%

Preferred Dividend and Other Adjustments

aa.aa

Net Income to Common Excl. Extra Items

aa.aa

5.12

5.87

6.77

Basic EPS - Continuing Operations

aa.aa

1.1

1.29

Basic EPS - Continuing Operations Growth

aa.aa

+17.28%

Diluted EPS - Continuing Operations

aa.aa

1.1

1.29

Diluted EPS - Continuing Operations Growth

aa.aa

+17.28%

Basic Weighted Average Shares Outstanding

aa.aa

5.33

5.24

Diluted Weighted Average Shares Outstanding

aa.aa

5.33

5.24

Dividend Per Share

aa.aa

0.3

0.25

0.2

Dividend Per Share Growth

aa.aa

-16.67%

-20%

EBITDA

aa.aa

13.59

15.05

17.58

EBITDA Growth

aa.aa

+22.7%

+10.78%

+16.82%

EBITDA Margin %

aa.aa

11.17%

12.31%

12.42%

EBIT

aa.aa

8.57

9.8

12.24

* In Millions of EUR (except for per share items)

FAQ

What was Svas Biosana’s revenue at year end?

At the end of the last reported fiscal year, Svas Biosana (SVSB) recorded total revenue of 141.56 million EUR.

What was Svas Biosana’s net income for the year?

For the full year, Svas Biosana reported net income of 6.77 million EUR.

What was Svas Biosana’s gross profit for the year?

Gross profit for the year was reported at 40.08 million EUR.

What was Svas Biosana’s annual operating income?

For the full year, Svas Biosana (SVSB) reported operating income of 12.24 million EUR.

S&P/TSX

36,401.79

+33.86

+0.09%

S&P/TSX 60

2,136.14

-7.72

-0.36%

US 30

53,477.50

+133.9

+0.25%

US 500

7,713.00

+21.0

+0.27%

S&P 500 VIX

14.89

-0.95

-6.00%

DAX

26,091.33

-37.03

-0.14%

Dollar Index

98.69

-0.860

-0.87%

Market Movers

Name	Last	Chg. %	Vol.
RBC	286.92	-3.15%	4.85M
Canadian Natural	68.48	-0.74%	15.37M
Enbridge	69.49	-2.69%	14.71M
Manulife Financial	60.06	-1.96%	15.65M
Toronto Dominion Bank	163.64	-3.53%	4.93M
Bank of Montreal	242.62	-4.44%	3.02M
Suncor Energy	93.30	-0.97%	6.62M

Name	Last	Chg. %	Vol.
Asep Medical Holdings	0.39	+609.09%	3.00K
Green Scientific Labs Holdings	0.06	+120.00%	15.00K
Martello Tech	0.0100	+100.00%	14.00K
Blue Horizon Global Capital	0.010	+100.00%	12.00K
Beckett’s	0.010	+100.00%	5.00K
ePlay Digital	0.010	+100.00%	7.00K
LFNT Resources	0.20	+90.48%	17.50K

Name	Last	Chg. %	Vol.
Patriot Gold	0.01	-87.50%	1.00K
Lanebury Growth Capital	0.05	-68.75%	18.17K
EnviroMetal Technologies	0.01	-50.00%	34.06K
Molecule Holdings	0.005	-50.00%	20.11K
James Bay Resources Ltd	0.010	-50.00%	1.00K
Albert Labs International	0.005	-50.00%	1.00K
Playground Ventures	0.010	-50.00%	1.00K

Trending Stocks

Name	Last	Chg. %	Vol.
Celestica Inc.	416.59	-3.56%	701.99K
Keel Infra	4.47	+1.13%	6.66M
Toronto Dominion Bank	163.64	-3.53%	4.93M
HIVE Digital Tech	3.8800	+0.78%	4.55M
Canadian Imperial Bank	162.93	-3.69%	3.17M

Most Undervalued Stocks

Name	Last	Upside	Fair Value
Aaaaa Aa Aaaaaaa	103.51	+42.44%	147.44
Aaaaaaaaaa A	7.38	+27.79%	9.43
A Aaaa	7.060	+27.75%	9.019
Aaaaaaa	6.340	+26.77%	8.037
Aaaaaaaa Aaa Aaaa	32.71	+24.73%	40.80
Aaaaaa	105.00	+18.10%	124.00
Aaaaaaaaaa	50.45	+16.96%	59.01

Name	Last	Upside	Fair Value
Aaaaa Aa Aaaaaaa	103.51	+42.44%	147.44
Aaaaaaaaaa A	7.38	+27.79%	9.43
A Aaaa	7.060	+27.75%	9.019
Aaaaaaa	6.340	+26.77%	8.037
Aaaaaaaa Aaa Aaaa	32.71	+24.73%	40.80
Aaaaaa	105.00	+18.10%	124.00
Aaaaaaaaaa	50.45	+16.96%	59.01

See full list

Install Our AppScan QR code to install app

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

Popular Searches

Please try another search

Svas Biosana SpA (SVSB)

SVSB Income Statement

FAQ

What was Svas Biosana’s revenue at year end?

What was Svas Biosana’s net income for the year?

What was Svas Biosana’s gross profit for the year?

What was Svas Biosana’s annual operating income?

Trending Stocks